Connection

Ali Rizvi to Tubulin Modulators

Back to Details
This is a "connection" page, showing publications Ali Rizvi has written about Tubulin Modulators.
Ali Rizvi
Connection Strength
0.112
Tubulin Modulators
  1. Everolimus-eluting stents in patients undergoing percutaneous coronary intervention: final 3-year results of the Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With de Novo Native Coronary Artery Lesions trial. Am Heart J. 2013 Dec; 166(6):1035-42.
    View in: PubMed
    Score: 0.112
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.